Q3 FY2024 Earnings
Financial report interval: 2024.06.30 - 2024.09.30
Overview: Singular Genomics(OMIC) the Revenue is 406 K (-12.12%);the EBIT is -18.07 M (+26.36%);the EPS is -6.72 (+27.41%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B12.12%
----
----
EBIT
-0.02B26.36%
----
----
EPS
-6.715127.41%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf